Selected research
Market Analysis & Forecast
Global Contraceptive Devices Market Analysis and Forecast 2026-2032
Market perspective
The global Contraceptive Devices market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Contraceptive Devices is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Contraceptive Devices is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Contraceptive Devices is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Contraceptive Devices is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global manufacturers of Contraceptive Devices include Actavis, Agile Therapeutics, Ansell, Caya, Church & Dwight, Condomi Health, HLL Lifecare, Karex Industries and Medicines360, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Contraceptive Devices, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Contraceptive Devices, also provides the sales of main regions and countries. Of the upcoming market potential for Contraceptive Devices, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Contraceptive Devices sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Contraceptive Devices market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Contraceptive Devices sales, projected growth trends, production technology, application and end-user industry.
Contraceptive Devices Segment by Company
Actavis
Agile Therapeutics
Ansell
Caya
Church & Dwight
Condomi Health
HLL Lifecare
Karex Industries
Medicines360
Okamoto Industries
The Female Health Company
TodaySponge
Bayer
Merck & Co
Teva Pharmaceutical
Contraceptive Devices Segment by Type
Male Contraceptive Devices
Female Contraceptive Devices
Contraceptive Devices Segment by Application
E-Commerce
Retail Pharmacy
Online Pharmacy
Hospital Pharmacy
Others
Contraceptive Devices Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Contraceptive Devices market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Contraceptive Devices and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Contraceptive Devices.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Contraceptive Devices in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Contraceptive Devices manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Contraceptive Devices sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Male Contraceptive Devices
- Female Contraceptive Devices
Applications
- E-Commerce
- Retail Pharmacy
- Online Pharmacy
- Hospital Pharmacy
- Others
Companies covered
- Actavis
- Agile Therapeutics
- Ansell
- Caya
- Church & Dwight
- Condomi Health
- HLL Lifecare
- Karex Industries
- Medicines360
- Okamoto Industries
- The Female Health Company
- TodaySponge
- Bayer
- Merck & Co
- Teva Pharmaceutical
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Contraceptive Devices Market by Type
- 1.2.1 Global Contraceptive Devices Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Male Contraceptive Devices
- 1.2.3 Female Contraceptive Devices
- 1.3 Contraceptive Devices Market by Application
- 1.3.1 Global Contraceptive Devices Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 E-Commerce
- 1.3.3 Retail Pharmacy
- 1.3.4 Online Pharmacy
- 1.3.5 Hospital Pharmacy
- 1.3.6 Others
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Contraceptive Devices Market Dynamics
- 2.1 Contraceptive Devices Industry Trends
- 2.2 Contraceptive Devices Industry Drivers
- 2.3 Contraceptive Devices Industry Opportunities and Challenges
- 2.4 Contraceptive Devices Industry Restraints
3 Global Market Growth Prospects
- 3.1 Global Contraceptive Devices Revenue Estimates and Forecasts (2021-2032)
- 3.2 Global Contraceptive Devices Revenue by Region
- 3.2.1 Global Contraceptive Devices Revenue by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Contraceptive Devices Revenue by Region (2021-2026)
- 3.2.3 Global Contraceptive Devices Revenue by Region (2027-2032)
- 3.2.4 Global Contraceptive Devices Revenue Market Share by Region (2021-2032)
- 3.3 Global Contraceptive Devices Sales Estimates and Forecasts 2021-2032
- 3.4 Global Contraceptive Devices Sales by Region
- 3.4.1 Global Contraceptive Devices Sales by Region: 2021 VS 2025 VS 2032
- 3.4.2 Global Contraceptive Devices Sales by Region (2021-2026)
- 3.4.3 Global Contraceptive Devices Sales by Region (2027-2032)
- 3.4.4 Global Contraceptive Devices Sales Market Share by Region (2021-2032)
- 3.5 US & Canada & Mexico
- 3.6 Europe
- 3.7 China
- 3.8 Asia (Excluding China)
- 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
- 4.1 Global Contraceptive Devices Revenue by Manufacturers
- 4.1.1 Global Contraceptive Devices Revenue by Manufacturers (2021-2026)
- 4.1.2 Global Contraceptive Devices Revenue Market Share by Manufacturers (2021-2026)
- 4.1.3 Global Contraceptive Devices Manufacturers Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Contraceptive Devices Sales by Manufacturers
- 4.2.1 Global Contraceptive Devices Sales by Manufacturers (2021-2026)
- 4.2.2 Global Contraceptive Devices Sales Market Share by Manufacturers (2021-2026)
- 4.2.3 Global Contraceptive Devices Manufacturers Sales Share Top 10 and Top 5 in 2025
- 4.3 Global Contraceptive Devices Sales Price by Manufacturers (2021-2026)
- 4.4 Global Contraceptive Devices Key Manufacturers Ranking, 2024 VS 2025 VS 2026
- 4.5 Global Contraceptive Devices Key Manufacturers Manufacturing Sites & Headquarters
- 4.6 Global Contraceptive Devices Manufacturers, Product Type & Application
- 4.7 Global Contraceptive Devices Manufacturers' Establishment Date
- 4.8 Market Competitive Analysis
- 4.8.1 Global Contraceptive Devices Market CR5 and HHI
- 4.8.2 2025 Contraceptive Devices Tier 1, Tier 2, and Tier 3
5 Contraceptive Devices Market by Type
- 5.1 Global Contraceptive Devices Revenue by Type
- 5.1.1 Global Contraceptive Devices Revenue by Type (2021 VS 2025 VS 2032)
- 5.1.2 Global Contraceptive Devices Revenue by Type (2021-2032) & (US$ Million)
- 5.1.3 Global Contraceptive Devices Revenue Market Share by Type (2021-2032)
- 5.2 Global Contraceptive Devices Sales by Type
- 5.2.1 Global Contraceptive Devices Sales by Type (2021 VS 2025 VS 2032)
- 5.2.2 Global Contraceptive Devices Sales by Type (2021-2032) & (W Units)
- 5.2.3 Global Contraceptive Devices Sales Market Share by Type (2021-2032)
- 5.3 Global Contraceptive Devices Price by Type
6 Contraceptive Devices Market by Application
- 6.1 Global Contraceptive Devices Revenue by Application
- 6.1.1 Global Contraceptive Devices Revenue by Application (2021 VS 2025 VS 2032)
- 6.1.2 Global Contraceptive Devices Revenue by Application (2021-2032) & (US$ Million)
- 6.1.3 Global Contraceptive Devices Revenue Market Share by Application (2021-2032)
- 6.2 Global Contraceptive Devices Sales by Application
- 6.2.1 Global Contraceptive Devices Sales by Application (2021 VS 2025 VS 2032)
- 6.2.2 Global Contraceptive Devices Sales by Application (2021-2032) & (W Units)
- 6.2.3 Global Contraceptive Devices Sales Market Share by Application (2021-2032)
- 6.3 Global Contraceptive Devices Price by Application
7 Company Profiles
- 7.1 Actavis
- 7.1.1 Actavis Company Information
- 7.1.2 Actavis Business Overview
- 7.1.3 Actavis Contraceptive Devices Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.1.4 Actavis Contraceptive Devices Product Portfolio
- 7.1.5 Actavis Recent Developments
- 7.2 Agile Therapeutics
- 7.2.1 Agile Therapeutics Company Information
- 7.2.2 Agile Therapeutics Business Overview
- 7.2.3 Agile Therapeutics Contraceptive Devices Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.2.4 Agile Therapeutics Contraceptive Devices Product Portfolio
- 7.2.5 Agile Therapeutics Recent Developments
- 7.3 Ansell
- 7.3.1 Ansell Company Information
- 7.3.2 Ansell Business Overview
- 7.3.3 Ansell Contraceptive Devices Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.3.4 Ansell Contraceptive Devices Product Portfolio
- 7.3.5 Ansell Recent Developments
- 7.4 Caya
- 7.4.1 Caya Company Information
- 7.4.2 Caya Business Overview
- 7.4.3 Caya Contraceptive Devices Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.4.4 Caya Contraceptive Devices Product Portfolio
- 7.4.5 Caya Recent Developments
- 7.5 Church & Dwight
- 7.5.1 Church & Dwight Company Information
- 7.5.2 Church & Dwight Business Overview
- 7.5.3 Church & Dwight Contraceptive Devices Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.5.4 Church & Dwight Contraceptive Devices Product Portfolio
- 7.5.5 Church & Dwight Recent Developments
- 7.6 Condomi Health
- 7.6.1 Condomi Health Company Information
- 7.6.2 Condomi Health Business Overview
- 7.6.3 Condomi Health Contraceptive Devices Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.6.4 Condomi Health Contraceptive Devices Product Portfolio
- 7.6.5 Condomi Health Recent Developments
- 7.7 HLL Lifecare
- 7.7.1 HLL Lifecare Company Information
- 7.7.2 HLL Lifecare Business Overview
- 7.7.3 HLL Lifecare Contraceptive Devices Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.7.4 HLL Lifecare Contraceptive Devices Product Portfolio
- 7.7.5 HLL Lifecare Recent Developments
- 7.8 Karex Industries
- 7.8.1 Karex Industries Company Information
- 7.8.2 Karex Industries Business Overview
- 7.8.3 Karex Industries Contraceptive Devices Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.8.4 Karex Industries Contraceptive Devices Product Portfolio
- 7.8.5 Karex Industries Recent Developments
- 7.9 Medicines360
- 7.9.1 Medicines360 Company Information
- 7.9.2 Medicines360 Business Overview
- 7.9.3 Medicines360 Contraceptive Devices Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.9.4 Medicines360 Contraceptive Devices Product Portfolio
- 7.9.5 Medicines360 Recent Developments
- 7.10 Okamoto Industries
- 7.10.1 Okamoto Industries Company Information
- 7.10.2 Okamoto Industries Business Overview
- 7.10.3 Okamoto Industries Contraceptive Devices Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.10.4 Okamoto Industries Contraceptive Devices Product Portfolio
- 7.10.5 Okamoto Industries Recent Developments
- 7.11 The Female Health Company
- 7.11.1 The Female Health Company Company Information
- 7.11.2 The Female Health Company Business Overview
- 7.11.3 The Female Health Company Contraceptive Devices Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.11.4 The Female Health Company Contraceptive Devices Product Portfolio
- 7.11.5 The Female Health Company Recent Developments
- 7.12 TodaySponge
- 7.12.1 TodaySponge Company Information
- 7.12.2 TodaySponge Business Overview
- 7.12.3 TodaySponge Contraceptive Devices Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.12.4 TodaySponge Contraceptive Devices Product Portfolio
- 7.12.5 TodaySponge Recent Developments
- 7.13 Bayer
- 7.13.1 Bayer Company Information
- 7.13.2 Bayer Business Overview
- 7.13.3 Bayer Contraceptive Devices Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.13.4 Bayer Contraceptive Devices Product Portfolio
- 7.13.5 Bayer Recent Developments
- 7.14 Merck & Co
- 7.14.1 Merck & Co Company Information
- 7.14.2 Merck & Co Business Overview
- 7.14.3 Merck & Co Contraceptive Devices Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.14.4 Merck & Co Contraceptive Devices Product Portfolio
- 7.14.5 Merck & Co Recent Developments
- 7.15 Teva Pharmaceutical
- 7.15.1 Teva Pharmaceutical Company Information
- 7.15.2 Teva Pharmaceutical Business Overview
- 7.15.3 Teva Pharmaceutical Contraceptive Devices Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.15.4 Teva Pharmaceutical Contraceptive Devices Product Portfolio
- 7.15.5 Teva Pharmaceutical Recent Developments
8 North America
- 8.1 North America Contraceptive Devices Market Size by Type
- 8.1.1 North America Contraceptive Devices Revenue by Type (2021-2032)
- 8.1.2 North America Contraceptive Devices Sales by Type (2021-2032)
- 8.1.3 North America Contraceptive Devices Price by Type (2021-2032)
- 8.2 North America Contraceptive Devices Market Size by Application
- 8.2.1 North America Contraceptive Devices Revenue by Application (2021-2032)
- 8.2.2 North America Contraceptive Devices Sales by Application (2021-2032)
- 8.2.3 North America Contraceptive Devices Price by Application (2021-2032)
- 8.3 North America Contraceptive Devices Market Size by Country
- 8.3.1 North America Contraceptive Devices Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 8.3.2 North America Contraceptive Devices Sales by Country (2021 VS 2025 VS 2032)
- 8.3.3 North America Contraceptive Devices Price by Country (2021-2032)
- 8.3.4 United States
- 8.3.5 Canada
9 Europe
- 9.1 Europe Contraceptive Devices Market Size by Type
- 9.1.1 Europe Contraceptive Devices Revenue by Type (2021-2032)
- 9.1.2 Europe Contraceptive Devices Sales by Type (2021-2032)
- 9.1.3 Europe Contraceptive Devices Price by Type (2021-2032)
- 9.2 Europe Contraceptive Devices Market Size by Application
- 9.2.1 Europe Contraceptive Devices Revenue by Application (2021-2032)
- 9.2.2 Europe Contraceptive Devices Sales by Application (2021-2032)
- 9.2.3 Europe Contraceptive Devices Price by Application (2021-2032)
- 9.3 Europe Contraceptive Devices Market Size by Country
- 9.3.1 Europe Contraceptive Devices Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 9.3.2 Europe Contraceptive Devices Sales by Country (2021 VS 2025 VS 2032)
- 9.3.3 Europe Contraceptive Devices Price by Country (2021-2032)
- 9.3.4 Germany
- 9.3.5 France
- 9.3.6 U.K.
- 9.3.7 Italy
- 9.3.8 Netherlands
10 China
- 10.1 China Contraceptive Devices Market Size by Type
- 10.1.1 China Contraceptive Devices Revenue by Type (2021-2032)
- 10.1.2 China Contraceptive Devices Sales by Type (2021-2032)
- 10.1.3 China Contraceptive Devices Price by Type (2021-2032)
- 10.2 China Contraceptive Devices Market Size by Application
- 10.2.1 China Contraceptive Devices Revenue by Application (2021-2032)
- 10.2.2 China Contraceptive Devices Sales by Application (2021-2032)
- 10.2.3 China Contraceptive Devices Price by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Contraceptive Devices Market Size by Type
- 11.1.1 Asia Contraceptive Devices Revenue by Type (2021-2032)
- 11.1.2 Asia Contraceptive Devices Sales by Type (2021-2032)
- 11.1.3 Asia Contraceptive Devices Price by Type (2021-2032)
- 11.2 Asia Contraceptive Devices Market Size by Application
- 11.2.1 Asia Contraceptive Devices Revenue by Application (2021-2032)
- 11.2.2 Asia Contraceptive Devices Sales by Application (2021-2032)
- 11.2.3 Asia Contraceptive Devices Price by Application (2021-2032)
- 11.3 Asia Contraceptive Devices Market Size by Country
- 11.3.1 Asia Contraceptive Devices Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 11.3.2 Asia Contraceptive Devices Sales by Country (2021 VS 2025 VS 2032)
- 11.3.3 Asia Contraceptive Devices Price by Country (2021-2032)
- 11.3.4 Japan
- 11.3.5 South Korea
- 11.3.6 India
- 11.3.7 Australia
- 11.3.8 Taiwan
- 11.3.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Contraceptive Devices Market Size by Type
- 12.1.1 SAMEA Contraceptive Devices Revenue by Type (2021-2032)
- 12.1.2 SAMEA Contraceptive Devices Sales by Type (2021-2032)
- 12.1.3 SAMEA Contraceptive Devices Price by Type (2021-2032)
- 12.2 SAMEA Contraceptive Devices Market Size by Application
- 12.2.1 SAMEA Contraceptive Devices Revenue by Application (2021-2032)
- 12.2.2 SAMEA Contraceptive Devices Sales by Application (2021-2032)
- 12.2.3 SAMEA Contraceptive Devices Price by Application (2021-2032)
- 12.3 SAMEA Contraceptive Devices Market Size by Country
- 12.3.1 SAMEA Contraceptive Devices Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 12.3.2 SAMEA Contraceptive Devices Sales by Country (2021 VS 2025 VS 2032)
- 12.3.3 SAMEA Contraceptive Devices Price by Country (2021-2032)
- 12.3.4 Brazil
- 12.3.5 Argentina
- 12.3.6 Chile
- 12.3.7 Colombia
- 12.3.8 Peru
- 12.3.9 Saudi Arabia
- 12.3.10 Israel
- 12.3.11 UAE
- 12.3.12 Turkey
- 12.3.13 Iran
- 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
- 13.1 Contraceptive Devices Value Chain Analysis
- 13.1.1 Contraceptive Devices Key Raw Materials
- 13.1.2 Raw Materials Key Suppliers
- 13.1.3 Manufacturing Cost Structure
- 13.1.4 Contraceptive Devices Production Mode & Process
- 13.2 Contraceptive Devices Sales Channels Analysis
- 13.2.1 Direct Comparison with Distribution Share
- 13.2.2 Contraceptive Devices Distributors
- 13.2.3 Contraceptive Devices Customers
14 Concluding Insights
15 Appendix
- 15.1 Reasons for Doing This Study
- 15.2 Research Methodology
- 15.3 Research Process
- 15.4 Authors List of This Report
- 15.5 Data Source
- 15.5.1 Secondary Sources
- 15.5.2 Primary Sources
- 15.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst